Genvoya (Page 11 of 11)

PRINCIPAL DISPLAY PANEL — 30 Tablet Bottle Label

NDC 61958-1901 -1
30 tablets

Genvoya®
(elvitegravir, cobicistat,
emtricitabine, and tenofovir
alafenamide) Tablets
150 mg/150 mg/200 mg/10 mg

Note to pharmacist:
Do not cover ALERT box with pharmacy label.

ALERT: Find out about medicines that should NOT be taken with Genvoya®

Principal Display Panel -- 30 Tablet Bottle Label
(click image for full-size original)
GENVOYA elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61958-1901
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
elvitegravir (elvitegravir) elvitegravir 150 mg
cobicistat (cobicistat) cobicistat 150 mg
emtricitabine (emtricitabine) emtricitabine 200 mg
tenofovir alafenamide fumarate (tenofovir anhydrous) tenofovir alafenamide 10 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MICROCRYSTALLINE CELLULOSE
HYDROXYPROPYL CELLULOSE (1600000 WAMW)
SODIUM LAURYL SULFATE
CROSCARMELLOSE SODIUM
WATER
MAGNESIUM STEARATE
POLYVINYL ALCOHOL, UNSPECIFIED
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL, UNSPECIFIED
TALC
FD&C BLUE NO. 2
FERRIC OXIDE YELLOW
Product Characteristics
Color GREEN Score no score
Shape OVAL (capsule-shaped) Size 19mm
Flavor Imprint Code GSI;510
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61958-1901-1 30 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA207561 11/05/2015
Labeler — Gilead Sciences, Inc. (185049848)

Revised: 01/2022 Gilead Sciences, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.